日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Smart Monitoring for Cancer Treatment: Feasibility Study of an IoT-Based Assessment System

癌症治疗智能监测:基于物联网的评估系统可行性研究

Martínez-Pascual, David; Rubira-Úbeda, Pablo; Catalán, José M; Blanco-Ivorra, Andrea; Franqueza, Beatriz; Derrico, Gabrielle; Barios, Juan A; García-Aracil, Nicolás

[Systematic review of the prognostic utility of D-dimer, disseminated intravascular coagulation, and anticoagulant therapy in COVID-19 critically ill patients]

[D-二聚体、弥散性血管内凝血和抗凝治疗在COVID-19危重患者预后价值中的系统评价]

Franqueza, J L; Rosas, E; Ioan, A-M; Durante-López, A; Pérez-Calvo, C; Santos, A; Serrano-Martínez, JL; Machado-Casas, JF; Redondo-Orts, M; Manzano-Manzano, F; Castaño-Pérez, J; Pérez-Villares, JM; Moreno, G; Carbonell, R; Bodí, M; Rodríguez, A

When success means focusing on the oxygen delivery. A case of conventional management of severe hypoxemia in SARS-CoV-2

当成功意味着专注于氧气输送时:SARS-CoV-2 严重低氧血症的常规治疗案例

Franqueza, J L; Rosas, E; Ioan, A-M; Durante-López, A; Pérez-Calvo, C; Santos, A

Mechanisms of block of a human cloned potassium channel by the enantiomers of a new bradycardic agent: S-16257-2 and S-16260-2

新型缓脉药物 S-16257-2 和 S-16260-2 的对映体阻断人克隆钾通道的机制

Delpón, E; Valenzuela, C; Pérez, O; Franqueza, L; Gay, P; Snyders, D J; Tamargo, J

Effects of the two enantiomers, S-16257-2 and S-16260-2, of a new bradycardic agent on guinea-pig isolated cardiac preparations

一种新型缓脉药物的两种对映异构体S-16257-2和S-16260-2对豚鼠离体心脏制剂的影响

Pérez, O; Gay, P; Franqueza, L; Carrón, R; Valenzuela, C; Delpón, E; Tamargo, J